Boothbay Fund Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-240,758
Closed -$609K 2068
2023
Q4
$609K Sell
240,758
-56,073
-19% -$131K 0.02% 911
2023
Q3
$709K Buy
296,831
+23,409
+9% +$51.8K 0.02% 903
2023
Q2
$632K Sell
273,422
-11,741
-4% -$33.1K 0.01% 1002
2023
Q1
$727K Buy
285,163
+16,762
+6% +$48K 0.01% 1124
2022
Q4
$674K Buy
268,401
+67,617
+34% +$189K 0.02% 1057
2022
Q3
$582K Buy
200,784
+48,036
+31% +$202K 0.01% 1149
2022
Q2
$690K Buy
152,748
+30,281
+25% +$180K 0.02% 1003
2022
Q1
$982K Buy
122,467
+96,212
+366% +$848K 0.02% 912
2021
Q4
$306K Buy
26,255
+4,437
+20% +$53.1K 0.01% 1244
2021
Q3
$270K Buy
+21,818
New +$246K 0.01% 1387

Boothbay Fund Management's SLGC Position: Q1 2024 in Review

Boothbay Fund Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 240,758 shares — an estimated $609K sold.

Boothbay Fund Management first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $982K in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Boothbay Fund Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 240,758 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $609K.
  • Boothbay Fund Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Boothbay Fund Management's SomaLogic, Inc. Class A Common Stock position peaked at $982K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.